Bioventures Ltd Novartis serves as Executive at Marina Biotech, Inc., where they oversee executive responsibilities. Since joining the company, Bioventures Ltd Novartis has executed 119 insider transactions totaling $21.9M, demonstrating a bearish approach to their equity position. Their most recent transaction on Dec 15, 2017 involved transacting 65,718 shares valued at $0.
Bioventures Ltd Novartis currently holds 2,467,961 shares of Marina Biotech, Inc. (MRNA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Bioventures Ltd Novartis has been a net seller of MRNA stock. They have purchased $9.6M and sold $12.3M worth of shares.
Bioventures Ltd Novartis's most recent insider trade was on Dec 15, 2017, when they sold 65,718 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Jun 5, 2017 | RARX | $110.5K | Sale | 4,780 | $23.11 | Discretionary |
| Jun 2, 2017 | RARX | $348.9K | Sale | 14,867 | $23.47 | Discretionary |
| May 18, 2017 | RARX | $230.0K | Sale | 9,019 | $25.50 | Discretionary |
| Mar 15, 2017 | NONE | $2.8M | Purchase | 560,000 | $5.00 | Discretionary |
| Jun 16, 2015 | TKAI | $16.0K | Sale | 1,120 | $14.27 | Discretionary |
| Jun 11, 2015 | TKAI | $395.8K | Sale | 27,875 | $14.20 | Discretionary |
| Mar 25, 2014 | AKBA | $0 | Conversion | 3,223,174 | $N/A | Discretionary |
| Mar 25, 2014 | AKBA | $3.1M | Purchase | 182,590 | $17.00 | Discretionary |
| Feb 4, 2014 | CLDN | $0 | Conversion | 1,372,798 | $N/A | Discretionary |
| Feb 4, 2014 | CLDN | $1.3M | Purchase | 162,386 | $8.00 | Discretionary |
| Feb 4, 2014 | CLDN | $132.3K | Conversion | 16,537 | $8.00 | Discretionary |
| Jan 26, 2011 | MRNA | $1.1K | Sale | 1,000 | $1.08 | Discretionary |
| Jan 26, 2011 | MRNA | $2.0K | Sale | 1,800 | $1.11 | Discretionary |
| Jan 26, 2011 | MRNA | $4.6K | Sale | 3,780 | $1.21 | Discretionary |
| Jan 26, 2011 | MRNA | $2.5K | Sale | 2,056 | $1.20 | Discretionary |
| Jan 26, 2011 | MRNA | $12.8K | Sale | 10,730 | $1.19 | Discretionary |
| Jan 26, 2011 | MRNA | $19.8K | Sale | 16,784 | $1.18 | Discretionary |
| Jan 26, 2011 | MRNA | $22.9K | Sale | 19,550 | $1.17 | Discretionary |
| Jan 26, 2011 | MRNA | $12.4K | Sale | 10,700 | $1.16 | Discretionary |
| Jan 26, 2011 | MRNA | $2.2K | Sale | 1,900 | $1.15 | Discretionary |
| Jan 26, 2011 | MRNA | $1.5K | Sale | 1,300 | $1.14 | Discretionary |
| Jan 26, 2011 | MRNA | $2.9K | Sale | 2,600 | $1.13 | Discretionary |
| Jan 26, 2011 | MRNA | $1.3K | Sale | 1,200 | $1.12 | Discretionary |
| Jan 26, 2011 | MRNA | $763 | Sale | 700 | $1.09 | Discretionary |
| Jan 26, 2011 | MRNA | $440 | Sale | 400 | $1.10 | Discretionary |
| Jan 25, 2011 | MRNA | $840 | Sale | 700 | $1.20 | Discretionary |
| Jan 25, 2011 | MRNA | $472 | Sale | 400 | $1.18 | Discretionary |
| Jan 25, 2011 | MRNA | $784 | Sale | 670 | $1.17 | Discretionary |